Video
Blood pressure and lipid abnormalities in metabolic syndrome stem from the same underlying mechanisms: insulin resistance, visceral adiposity, dyslipidaemia, and chronic inflammation.
Effective management emphasises weight reduction, dietary change, and physical activity, which simultaneously improve hypertension and triglycerides, increase HDL levels, and decrease LDL levels. When lifestyle measures are insufficient, blood pressure and cholesterol medications are added to reduce cardiovascular risk.
Presenter
Gerry Wilkins
Gerry is currently Professor of Medicine, Otago University and Consultant Cardiologist at Dunedin and Mercy Hospitals.
He was involved in the earliest use of coronary angioplasty in New Zealand in 1981-1984. He has continued a pioneering interest in vascular intervention and has been involved in the introduction of many new techniques, devices and trials, including the first use of coronary stents in NZ.
Supported by an unrestricted educational grant from:
